Novartis
NVS
939 hedge funds and large institutions have $23.3B invested in Novartis in 2015 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 313 increasing their positions, 375 reducing their positions, and 51 closing their positions.
63% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 51
40% more call options, than puts
Call options by funds: $43.8M | Put options by funds: $31.2M
11% more funds holding in top 10
Funds holding in top 10: 62 → 69 (+7)
2% more funds holding
Funds holding: 918 → 939 (+21)
5% more capital invested
Capital invested by funds: $22.3B → $23.3B (+$1.06B)
0.11% less ownership
Funds ownership: 9.77% → 9.67% (-0.11%)
17% less repeat investments, than reductions
Existing positions increased: 313 | Existing positions reduced: 375
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$173M |
| 2 |
Aristotle Capital Management
Los Angeles,
California
|
+$162M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$77.8M |
| 4 |
Jennison Associates
New York
|
+$76.5M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
-$171M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$139M |
| 3 |
Neuberger Berman Group
New York
|
-$125M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$49.7M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$48.1M |
NVS Hedge Fund Activity: Q1 2015 in Review
939 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q1 2015, worth a combined $23.3B — up 4.7% from $22.3B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new NVS positions and 51 closed out — a net gain of 32 holders — while 313 added to existing stakes and 375 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $173M. The largest seller was Sound Shore Management, exiting entirely with an estimated $171M sold.
- 939 institutional investors held Novartis (NVS) as of Q1 2015, up from 918 in Q4 2014.
- Funds reported $23.3B of Novartis stock for Q1 2015, up 4.7% quarter-over-quarter.
- 83 funds opened new Novartis positions in Q1 2015 and 51 closed out, a net change of +32 holders.
- The largest Novartis buyer in Q1 2015 was Fidelity Investments, an estimated $173M added.
- The largest Novartis seller in Q1 2015 was Sound Shore Management, an estimated $171M sold.
Based on aggregated 13F filings for Q1 2015.